SANUWAVE Health Statistics
Total Valuation
SANUWAVE Health has a market cap or net worth of $257.31 million. The enterprise value is $275.68 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, after market close.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SANUWAVE Health has 8.55 million shares outstanding. The number of shares has increased by 132.22% in one year.
| Current Share Class | 8.55M |
| Shares Outstanding | 8.55M |
| Shares Change (YoY) | +132.22% |
| Shares Change (QoQ) | +1.59% |
| Owned by Insiders (%) | 6.77% |
| Owned by Institutions (%) | 0.18% |
| Float | 4.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.84 |
| Forward PS | n/a |
| PB Ratio | -14.88 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.62 |
| EV / EBITDA | 31.79 |
| EV / EBIT | 36.99 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.40
| Current Ratio | 0.40 |
| Quick Ratio | 0.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.10 |
| Debt / FCF | n/a |
| Interest Coverage | 0.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 17.20% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -45.41% |
| Revenue Per Employee | $786,739 |
| Profits Per Employee | -$706,957 |
| Employee Count | 46 |
| Asset Turnover | 1.34 |
| Inventory Turnover | 2.14 |
Taxes
In the past 12 months, SANUWAVE Health has paid $27,000 in taxes.
| Income Tax | 27,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +264.85% in the last 52 weeks. The beta is 1.25, so SANUWAVE Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +264.85% |
| 50-Day Moving Average | 30.82 |
| 200-Day Moving Average | 20.39 |
| Relative Strength Index (RSI) | 50.02 |
| Average Volume (20 Days) | 56,188 |
Short Selling Information
The latest short interest is 19,636, so 0.23% of the outstanding shares have been sold short.
| Short Interest | 19,636 |
| Short Previous Month | 15,621 |
| Short % of Shares Out | 0.23% |
| Short % of Float | 0.43% |
| Short Ratio (days to cover) | 0.37 |
Income Statement
In the last 12 months, SANUWAVE Health had revenue of $36.19 million and -$32.52 million in losses. Loss per share was -$5.58.
| Revenue | 36.19M |
| Gross Profit | 27.73M |
| Operating Income | 7.45M |
| Pretax Income | n/a |
| Net Income | -32.52M |
| EBITDA | 8.67M |
| EBIT | 7.45M |
| Loss Per Share | -$5.58 |
Full Income StatementBalance Sheet
The company has $8.50 million in cash and $26.87 million in debt, giving a net cash position of -$18.37 million or -$2.15 per share.
| Cash & Cash Equivalents | 8.50M |
| Total Debt | 26.87M |
| Net Cash | -18.37M |
| Net Cash Per Share | -$2.15 |
| Equity (Book Value) | -17.29M |
| Book Value Per Share | -2.02 |
| Working Capital | -28.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$162,000 and capital expenditures -$538,000, giving a free cash flow of -$700,000.
| Operating Cash Flow | -162,000 |
| Capital Expenditures | -538,000 |
| Free Cash Flow | -700,000 |
| FCF Per Share | -$0.08 |
Full Cash Flow StatementMargins
Gross margin is 76.63%, with operating and profit margins of 20.59% and -89.86%.
| Gross Margin | 76.63% |
| Operating Margin | 20.59% |
| Pretax Margin | -89.78% |
| Profit Margin | -89.86% |
| EBITDA Margin | 23.96% |
| EBIT Margin | 20.59% |
| FCF Margin | n/a |